MAZE
Maze Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$28.37+0.89%
Price as of Jul 20, 2026
MAZE valuation
Maze Therapeutics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1570.15x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.60x
- Price / sales
- 78.51x
- Price / cash flow
- -12.92x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 63.95x
- EV / EBITDA
- -10.70x
- EV / EBIT
- -9.54x
- Market cap
- $1.6B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.